Ensayos clínicos de Migraña en Ohio
14 estudios sobre Migraña buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Ohio State University Wexner Medical Center, Columbus
ReclutandoFase 4
Edades de 18 a 70 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06972056Study of EVO756 in Adults With Migraine
- NeuroScience Research Center, Canton
- Dayton Center for Neurological Disorders, Centerville
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 13 nov 2026 · NCT07616128A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Velocity Clinical Research, Cleveland, Beachwood
- Velocity Clinical Research, Cincinnati, Blue Ash, Blue Ash
- Headache Center of Hope, Cincinnati
- y 1 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07816367A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Hometown Research, Columbus
- Hometown Research, Milford
- CincyScience, West Chester
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Cincinnati Children's Hospital, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 27 oct 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 27 oct 2026 · NCT04649242Overlapping Pain Trajectory Study
- Cincinnati Children's Hospital, Cincinnati
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 10 a 19 · Todos los sexos · Actualizado el 20 oct 2026 · NCT05752396Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 oct 2026 · NCT05156398A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center-Burnet Campus, Cincinnati
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 oct 2026 · NCT05164172A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 1
Edades de 6 a 11 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06995729Responding With Evidence and Access for Childhood Headaches
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Childrens, Columbus
Reclutando
Edades de 10 a 17 · Todos los sexos · Actualizado el 21 sept 2026 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Patient Priority Clinical Sites, LLC /ID# 238485, Cincinnati
- University Of Cincinnati Medical Center /ID# 231199, Cincinnati
- Cincinnati Childrens Hospital Medical Center /ID# 244689, Cincinnati
- y 3 más
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 sept 2026 · NCT05125302BE WELL With Migraine: Brain Education and WELLness With Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT05987592Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #4, Cincinnati
ReclutandoFase 4
Edades de 6 a 11 · Todos los sexos · Actualizado el 27 ene 2025 · NCT04748601De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.